TITLE

Genome-wide changes accompanying knockdown of fatty acid synthase in breast cancer

AUTHOR(S)
Knowles, Lynn M; Smith, Jeffrey W
PUB. DATE
January 2007
SOURCE
BMC Genomics;2007, Vol. 8, p168
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: The lipogenic enzyme fatty acid synthase (FAS) is up-regulated in a wide variety of cancers, and is considered a potential metabolic oncogene by virtue of its ability to enhance tumor cell survival. Inhibition of tumor FAS causes both cell cycle arrest and apoptosis, indicating FAS is a promising target for cancer treatment. Results: Here, we used gene expression profiling to conduct a global study of the cellular processes affected by siRNA mediated knockdown of FAS in MDA-MB-435 mammary carcinoma cells. The study identified 169 up-regulated genes ( 1.5 fold) and 110 down-regulated genes ( 0.67 fold) in response to knockdown of FAS. These genes regulate several aspects of tumor function, including metabolism, cell survival/proliferation, DNA replication/transcription, and protein degradation. Quantitative pathway analysis using Gene Set Enrichment Analysis software further revealed that the most pronounced effect of FAS knockdown was down-regulation in pathways that regulate lipid metabolism, glycolysis, the TCA cycle and oxidative phosphorylation. These changes were coupled with up-regulation in genes involved in cell cycle arrest and death receptor mediated apoptotic pathways. Conclusion: Together these findings reveal a wide network of pathways that are influenced in response to FAS knockdown and provide new insight into the role of this enzyme in tumor cell survival and proliferation.
ACCESSION #
28858841

 

Related Articles

  • Period-2: a tumor suppressor gene in breast cancer. Shulin Xiang; Coffelt, Seth B.; Lulu Mao; Lin Yuan; Qi Cheng; Hill, Steven M. // Journal of Circadian Rhythms;2008, Vol. 6, Special section p1 

    Previous reports have suggested that the ablation of the Period 2 gene (Per 2) leads to enhanced development of lymphoma and leukemia in mice. Employing immunoblot analyses, we have demonstrated that PER 2 is endogenously expressed in human breast epithelial cell lines but is not expressed or is...

  • Fatty Acid Metabolites in Rapidly Proliferating Breast Cancer O’Flaherty, Joseph T.; Wooten, Rhonda E.; Samuel, Michael P.; Thomas, Michael J.; Levine, Edward A.; Case, L. Douglas; Akman, Steven A.; Edwards, Iris J. // PLoS ONE;May2013, Vol. 8 Issue 5, p1 

    Purpose: Breast cancers that over-express a lipoxygenase or cyclooxygenase are associated with poor survival possibly because they overproduce metabolites that alter the cancer’s malignant behaviors. However, these metabolites and behaviors have not been identified. We here identify which...

  • Formalization, Annotation and Analysis of Diverse Drug and Probe Screening Assay Datasets Using the BioAssay Ontology (BAO). Vempati, Uma D.; Przydzial, Magdalena J.; Chung, Caty; Abeyruwan, Saminda; Mir, Ahsan; Sakurai, Kunie; Visser, Ubbo; Lemmon, Vance P.; Schürer, Stephan C. // PLoS ONE;Nov2012, Vol. 7 Issue 11, Special section p1 

    Huge amounts of high-throughput screening (HTS) data for probe and drug development projects are being generated in the pharmaceutical industry and more recently in the public sector. The resulting experimental datasets are increasingly being disseminated via publically accessible repositories....

  • Fatty acid metabolism in breast cancer cells: differential inhibitory effects of epigallocatechin gallate (EGCG) and C75. Joana Relat; Jordi Pétriz; Gemma Casals; Pedro Marrero; Diego Haro; Joan Brunet // Breast Cancer Research & Treatment;Jun2008, Vol. 109 Issue 3, p471 

    Abstract  Endogenous fatty acid metabolism is crucial to maintain the cancer cell malignant phenotype. Lipogenesis is regulated by the enzyme fatty acid synthase (FASN); and breakdown of fatty acids is regulated by carnitine palmitoyltransferase-1 (CPT-I). FASN is highly expressed in...

  • Immunoscoring breast cancer: TILs remember what they target. Curigliano, G.; Perez, E. A. // Annals of Oncology;Aug2014, Vol. 25 Issue 8, p1455 

    No abstract available.

  • CG0009, a Novel Glycogen Synthase Kinase 3 Inhibitor, Induces Cell Death through Cyclin D1 Depletion in Breast Cancer Cells. Kim, Hyun Mi; Kim, Choung-Soo; Lee, Je-Hwan; Jang, Se Jin; Hwang, Jung Jin; Ro, Seonggu; Choi, Jene // PLoS ONE;Apr2013, Vol. 8 Issue 4, p1 

    Glycogen synthase kinase 3α/β (GSK3α/β) is a constitutively active serine/threonine kinase involved in multiple physiological processes, such as protein synthesis, stem cell maintenance and apoptosis, and acts as a key suppressor of the Wnt-β-catenin pathway. In the present study,...

  • Induction of Endoplasmic Reticulum Stress Response by the Indole-3- Carbinol Cyclic Tetrameric Derivative CTet in Human Breast Cancer Cell Lines. Galluzzi, Luca; De Santi, Mauro; Crinelli, Rita; De Marco, Cinzia; Zaffaroni, Nadia; Duranti, Andrea; Brandi, Giorgio; Magnani, Mauro; Ahmad, Aamir // PLoS ONE;Aug2012, Vol. 7 Issue 8, Special section p1 

    Background: Indole-3-carbinol and its metabolic products are considered promising chemopreventive and anticancer agents. Previously we have shown that the indole-3-carbinol cyclic tetrameric derivative CTet induces autophagy and inhibits cell proliferation via inhibition of Akt activity and...

  • The Marine-Derived Fungus Clonostachys rosea, Source of a Rare Conjugated 4-Me-6E,8E-hexadecadienoic Acid Reducing Viability of MCF-7 Breast Cancer Cells and Gene Expression of Lipogenic Enzymes. Dos Santos Dias, Ana Camila; Ruiz, Nicolas; Couzinet-Mossion, Aurélie; Bertrand, Samuel; Duflos, Muriel; Pouchus, Yves-François; Barnathan, Gilles; Nazih, Hassan; Wielgosz-Collin, Gaetane // Marine Drugs;2015, Vol. 13 Issue 8, p4934 

    A marine-derived strain of Clonostachys rosea isolated from sediments of the river Loire estuary (France) was investigated for its high lipid production. The fungal strain was grown on six different culture media to explore lipid production changes. An original branched conjugated fatty acid,...

  • Genomic amplification and a role in drug-resistance for the KDM5A histone demethylase in breast cancer. Jinling Hou; Wu, Jack; Dombkowski, Alan; Kezhong Zhang; Holowatyj, Andreana; Boerner, Julie L.; Zeng-Quan Yang // American Journal of Translational Research;2012, Vol. 4 Issue 3, p247 

    Lysine-specific demethylase 5A (KDM5A), an enzyme that removes activating H3K4 di- and trimethylation marks, plays critical roles in controlling transcription and chromatin architecture, yet its biological functions largely remain uncharacterized, particularly in the context of human cancer. In...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics